Organ transplants. New drug blocks rejection in monkeys.
Vogel
G
G
D000818:Animals; D000906:Antibodies / Q000627:therapeutic use*; D019013:CD40 Antigens / Q000378:metabolism; D023201:CD40 Ligand; D002986:Clinical Trials as Topic; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D000882:Haplorhini; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D016381:Islets of Langerhans Transplantation; D016030:Kidney Transplantation; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins / Q000276:immunology* / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology
D000906:Antibodies; D019013:CD40 Antigens; D007166:Immunosuppressive Agents; D008562:Membrane Glycoproteins; D023201:CD40 Ligand